Cellular interactions and gene expression analysis of two equine-derived bone graft materials: an in vitro study.

Overview

• This study compares the biological properties of two equine-derived bone graft materials to a commonly used synthetic substitute, β-tricalcium phosphate, focusing on their effects on cell behavior and gene expression relevant to bone healing.
• The findings provide insights into which type of collagen-containing graft may be most effective for different bone repair scenarios.

Introduction to Bone Grafting and Materials

• Bone grafting is a surgical technique to repair bone damage using either natural bone tissue or synthetic bone substitutes.
• In dental and maxillofacial surgeries, various bone graft materials are employed to promote bone regeneration and structural support.
• Biological and mechanical properties of these graft substitutes are crucial, as they influence the success of clinical outcomes in bone repair.

Materials Studied

• Two equine-derived bone graft materials were assessed:
  • One containing hydrolyzed type I collagen
  • Another containing preserved (intact) type I collagen
• These were compared with β-tricalcium phosphate (β-TCP), a synthetic bone graft substitute widely used in clinical practice.

Methods

• In vitro testing was performed to evaluate:
  • Cell viability (whether cells remained alive and healthy when exposed to the materials)
  • Cell adhesion (ability of cells to attach to the graft materials)
  • Osteogenic differentiation (the process by which precursor cells mature into bone-forming cells)
  • Gene expression associated with bone remodeling (to understand molecular activity related to bone healing and resorption)

Key Results

• All materials were biocompatible, showing no cytotoxic effects on cells.
• β-TCP showed lack of intergranular tissue fibers and extracellular matrix before and after osteogenic differentiation, indicating limited bone matrix formation on this material.
• The equine-derived graft with hydrolyzed collagen supported the presence of intergranular tissue fibers and matrix, demonstrating active cell-matrix interactions.
• The graft with preserved type I collagen showed even more extensive intergranular tissue fibers, individual cells, and matrix formation, indicating superior biological performance.
• Gene expression analysis indicated:
  • Faster resorption kinetics for β-TCP, meaning it might be broken down quicker in the body.
  • Patterns suggestive of enhanced bone formation with the equine-derived grafts, particularly the preserved collagen type.

Conclusions and Clinical Implications

• Both hydrolyzed and preserved type I collagen bone grafts support bone matrix deposition better than β-TCP.
• Among the equine-derived grafts, preserved collagen showed superior performance regarding cellular repopulation and bone remodeling potential.
• Clinically:
  • Preserved collagen grafts might be more suitable for larger or less contained bone defects because they promote faster cell migration and remodeling.
  • Hydrolyzed collagen grafts might be better for smaller or localized defects where immediate biological activity is less critical due to a slower cellular response.
• The study emphasizes the need for further research to tailor bone graft selection to specific clinical contexts, optimizing patient outcomes.

Overall Significance

• This research advances understanding of how different types of collagen in bone graft substitutes influence cellular behavior and gene activity related to bone regeneration.
• The findings help inform dental and maxillofacial surgeons about the optimal choice of bone substitute materials based on the size and nature of the bone defect.